The Association of an Alpha-2 Adrenergic Receptor Agonist and Mortality in Patients With COVID-19

There is a need for treatments to reduce coronavirus disease 2019 (COVID-19) mortality. Alpha-2 adrenergic receptor (α2 AR) agonists can dampen immune cell and inflammatory responses as well as improve oxygenation through physiologic respiratory parameters. Therefore, α2 AR agonists may be effective...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	John L. Hamilton, Mona Vashi, Ekta B. Kishen, Louis F. Fogg, Markus A. Wimmer, Robert A. Balk
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Frontiers Media S.A. 2022-01-01
Serie:	Frontiers in Medicine
Ämnen:	coronavirus disease 2019 (COVID-19) dexmedetomidine mortality severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) alpha-2 adrenergic receptor agonist
Länkar:	https://www.frontiersin.org/articles/10.3389/fmed.2021.797647/full
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!